This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Qurient Co., Ltd.

Drug Names(s): Q701

Description: Q701 is a potent and selective TAM kinase-inhibitor being developed for cancer therapy. Q701 shows potent activity to inhibit metastasis and restore drug sensitivity of drug resistant tumor both in vitro and in vivo.

Q701 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug